Data as of Apr 17
| +0.02 / +0.12%|
The 2 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 16.00, with a high estimate of 19.00 and a low estimate of 13.00. The median estimate represents a -0.56% decrease from the last price of 16.09.
The current consensus among 2 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.